SEER

Seer Inc

1.68

Oct 30 • 3:59 PM ET -0.26 (-13.40%)

1.66

Aftermarket • 7:58 PM ET -0.02 (-1.19%)

Healthcare Biotechnology USA Micro NASD

Oct 29, 4:36 PMSeer special committee ends strategic review, unanimously rejects acquisition proposals from Radoff-JEC Group and CEO Omid Farokhzad

Peers: NAUT QSI QTRX LAB TECH BRKR TXG PACB TMO BNGO

| Held by: VTI VXF IWC BUSM AVSC DFMC PRFZ DFAS DFSU AVUS

Scroll to Statements

Index	-
Market Cap	93.02M
Enterprise Value	-37.44M
Income	-67.96M
Sales	14.09M
Book/sh	4.08
Cash/sh	2.76
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	124
IPO	Dec 04, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	6.60
P/B	0.41
P/C	0.61
P/FCF	-
EV/EBITDA	-
EV/Sales	-2.66
Quick Ratio	14.06
Current Ratio	14.74
Debt/Eq	0.10
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-1.22
EPS next Y	-1.06
EPS next Q	-0.26
EPS this Y	14.06%
EPS next Y	3.95%
EPS next 5Y	12.08%
EPS past 3/5Y	4.89% -18.95%
Sales past 3/5Y	3.15% 89.71%
EPS Y/Y TTM	12.29%
Sales Y/Y TTM	-13.23%
EPS Q/Q	8.40%
Sales Q/Q	-23.43%
Earnings	Nov 10 AMC
EPS/Sales Surpr.	-14.81% -12.62%

Insider Own	33.39%
Insider Trans	-0.14%
Inst Own	23.28%
Inst Trans	-0.33%
ROA	-23.47%
ROE	-26.45%
ROIC	-27.70%
Gross Margin	47.22%
Oper. Margin	-503.63%
Profit Margin	-482.39%
SMA20	-17.99%
SMA50	-16.23%
SMA200	-12.53%
Trades

Shs Outstand	55.30M
Shs Float	36.88M
Short Float	0.26%
Short Ratio	0.33
Short Interest	0.09M
52W High	2.38 -29.26%
52W Low	1.55 8.39%
Volatility	7.80% 5.18%
ATR (14)	0.11
RSI (14)	27.37
Beta	1.47
Rel Volume	1.79
Avg Volume	289.38K
Volume	516,545

Perf Week	-14.72%
Perf Month	-23.64%
Perf Quarter	-25.00%
Perf Half Y	-17.24%
Perf YTD	-8.20%
Perf Year	-24.66%
Perf 3Y	-0.59%
Perf 5Y	-95.45%
Perf 10Y	-
Recom	1.00
Target Price	4.00
Prev Close	1.94
Price	1.68
Change %	-13.40%

Consensus

Strong Buy

Avg. Price Target

$4.00

Implied Upside

+138.1%

Analysts5incl. previous ratings

Rating Distribution2 Buy · 2 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
May 04, 2026	Initiated	CCanaccord Genuity	Buy	$4	+138.1%
Jul 05, 2023	Resumed	JJP Morgan	Neutral	$10	+495.2%
Jan 04, 2023	Downgrade	BBofA Securities	Neutral → Underperform	$9 → $6.50	+286.9%
Aug 11, 2022	Downgrade	JJP Morgan	Overweight → Neutral	$20 → $12	+614.3%
Oct 15, 2021	Resumed	CCowen	Outperform
Dec 29, 2020	Initiated	MMorgan Stanley	Equal-Weight	$65	+3,769.0%
Dec 29, 2020	Initiated	JJP Morgan	Overweight	$75	+4,364.3%
Dec 29, 2020	Initiated	CCowen	Outperform
Dec 29, 2020	Initiated	BBofA Securities	Neutral	$69	+4,007.1%

Oct-29-26 04:30PM	Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process (GlobeNewswire) -13.40%
Oct-21-26 04:05PM	Seer to Report Third Quarter 2026 Financial Results on November 10, 2026 (GlobeNewswire)
Sep-23-26 07:00AM	Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026 (GlobeNewswire)
Sep-21-26 07:00AM	Seer Announces CFO Transition (GlobeNewswire)
Sep-16-26 08:00AM	Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale (GlobeNewswire)
08:00AM	Loading…
Sep-04-26 08:00AM	Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.s Board of Directors (Business Wire)
Aug-13-26 01:00PM	Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers (Business Wire)
Aug-12-26 01:02AM	Seer Inc (SEER) (Q2 2026) Earnings Call Highlights: Navigating Funding Headwinds While ... (GuruFocus.com)
Aug-11-26 04:05PM	Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook (GlobeNewswire)
Aug-10-26 09:24AM	Earnings To Watch: Seer Inc (SEER) Q2 2026 -- GF Value Sees 31% Upside (GuruFocus.com)
Aug-03-26 04:15PM	Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
04:05PM	Seer to Report Second Quarter 2026 Financial Results on August 11, 2026 (GlobeNewswire)
Jul-30-26 05:30PM	Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D. (GlobeNewswire) +7.77%
Jul-28-26 05:40PM	Seer Stockholders Vote to Re-Elect All Seven of Seer's Director Nominees at 2026 Annual Meeting (GlobeNewswire) +8.63%
12:47PM	Radoff-JEC Group Submits Further Improved Proposal to Acquire Seer, Inc. (Business Wire)
05:35PM	Loading…
Jul-23-26 05:35PM	Radoff-JEC Group Urges Seer Stockholders to Vote FOR All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY (Business Wire)
Jul-22-26 08:00AM	Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc. (Business Wire)
Jul-20-26 07:00AM	Seer Urges Stockholders to Vote "FOR" Seer's Highly Qualified Director Nominees on the BLUE Proxy Card TODAY (GlobeNewswire) -5.99%
06:00AM	Special Committee of Seer's Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. (GlobeNewswire)
Jul-17-26 08:20AM	Radoff-JEC Group Announces ISS Support of its Case for Change at Seer, Inc. (Business Wire)
Jul-14-26 04:05PM	Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight (GlobeNewswire)
Jul-08-26 06:04PM	The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Companys Blatant Rewriting of History (Business Wire)
07:00AM	Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer's Director Nominees (GlobeNewswire)
Jul-06-26 08:00AM	The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.s Proposal to Acquire Seer, Inc. (Business Wire) +35.19%
07:35AM	Seer Shares Rally 30% Following Investor Update Ahead of Annual Meeting (SEER) (InvestorsHub)
07:00AM	Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential (GlobeNewswire)
Jul-02-26 05:00PM	Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. (GlobeNewswire)
Jul-01-26 07:00AM	Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics (GlobeNewswire)
Jun-29-26 04:10PM	The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change (Business Wire)
Jun-24-26 08:45AM	The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today (Business Wire)
07:00AM	Loading…
Jun-22-26 07:00AM	Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening (GlobeNewswire)
Jun-15-26 08:00AM	The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction (Business Wire)
07:00AM	Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign (GlobeNewswire)
Jun-03-26 06:00PM	Seer Files Definitive Proxy Materials and Mails Letter to Stockholders (GlobeNewswire)
May-29-26 07:00AM	Seer Files ITC Complaint Against Nanomics (GlobeNewswire)
May-27-26 04:30PM	The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders (Business Wire)
May-26-26 04:05PM	Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026 (GlobeNewswire)
May-21-26 04:38PM	Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group (GlobeNewswire) +5.36%
May-14-26 08:00AM	The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc. (Business Wire)
01:01AM	Seer Inc (SEER) Q1 2026 Earnings Call Highlights: Navigating Revenue Decline Amid Competitive ... (GuruFocus.com)
May-13-26 04:05PM	Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook (GlobeNewswire)
07:00AM	Seer Files Patent Infringement Lawsuit Against Nanomics (GlobeNewswire)
May-12-26 09:22AM	Earnings To Watch: Seer Inc (SEER) Reports Q1 2026 Result (GuruFocus.com)
May-04-26 07:00AM	Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer (GlobeNewswire)
Apr-29-26 04:05PM	Seer to Report First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire)
08:00AM	The Radoff-JEC Group Responds to Seer, Inc.s Rejection of April 24th Acquisition Proposal (Business Wire)
Apr-27-26 07:00AM	Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group (GlobeNewswire)
Apr-24-26 07:00AM	The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc. (Business Wire)
Apr-13-26 01:55PM	Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group (GlobeNewswire) +13.61%
08:00AM	The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc. (Business Wire)
Apr-09-26 08:00AM	Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples (GlobeNewswire)
Mar-30-26 07:00AM	Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries (GlobeNewswire)
Mar-04-26 08:00AM	The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs (Business Wire)
Feb-27-26 05:45AM	Seer Q4 Earnings Call Highlights (MarketBeat) -17.31%
12:05AM	Seer Inc (SEER) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Funding Challenges (GuruFocus.com)
Feb-26-26 04:06PM	Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets (GlobeNewswire)
04:05PM	Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook (GlobeNewswire)
Feb-25-26 07:41AM	What To Expect From Seer Inc (SEER) Q4 2025 Earnings (GuruFocus.com)
Feb-23-26 08:30AM	The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change (Business Wire)
Feb-19-26 07:00AM	Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026 (GlobeNewswire)
Feb-18-26 04:05PM	Seer to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-05-26 04:05PM	Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Dec-01-25 07:00AM	Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers (GlobeNewswire)
Nov-07-25 07:00AM	Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 (GlobeNewswire)
Nov-06-25 04:05PM	Seer Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-05-25 07:59AM	Seer Inc (SEER) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-25 04:05PM	Seer to Participate in Upcoming November Investor Conferences (GlobeNewswire)
Oct-16-25 04:05PM	Seer to Report Third Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Oct-10-25 07:00AM	Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025 (GlobeNewswire)
Sep-02-25 07:00AM	Seer Appoints Isaac Ro to its Board of Directors (GlobeNewswire)
Aug-26-25 04:05PM	Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
Aug-06-25 06:45PM	Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook (GlobeNewswire)
Aug-05-25 10:31AM	Seer Inc (SEER) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-31-25 04:05PM	Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-22-25 04:05PM	Seer to Report Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jun-10-25 12:00PM	What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now? (Zacks)
Jun-01-25 07:00AM	Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults (GlobeNewswire)
May-29-25 07:00AM	Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency (GlobeNewswire)
May-14-25 08:10AM	Q1 2025 Seer Inc Earnings Call (Thomson Reuters StreetEvents) +9.90%
03:15AM	Seer Inc (SEER) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
May-13-25 05:15PM	Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook (GlobeNewswire)
May-12-25 09:44AM	What To Expect From Seer Inc (SEER) Q1 2025 Earnings (GuruFocus.com)
07:25AM	CytomX Therapeutics (CTMX) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-08-25 08:25AM	Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
May-05-25 05:45PM	AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-24-25 04:05PM	Seer to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Mar-25-25 09:35AM	After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) (Zacks)
Mar-24-25 09:35AM	After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) (Zacks)
Mar-06-25 09:35AM	Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround (Zacks)
Feb-28-25 11:38AM	Q4 2024 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
02:39AM	Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-27-25 06:40PM	Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook (GlobeNewswire)
Feb-26-25 08:16AM	Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-21-25 07:00AM	Seer to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-20-25 07:00AM	Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025 (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Horn David R.	PRESIDENT & CFO	Aug 18 '26	Sale	2.03	7,309	14,809	486,650	Aug 19 06:59 PM
Nishar Dipchand	Director	Jul 08 '26	Sale	2.18	10,660	23,265	59,044	Jul 10 06:23 PM
DIPCHAND NISHAR	Director	Jul 08 '26	Proposed Sale	2.18	10,660	23,265		Jul 08 04:03 PM
Horn David R.	PRESIDENT & CFO	May 20 '26	Sale	1.69	7,303	12,352	493,959	May 21 05:12 PM
Horn David R.	PRESIDENT & CFO	Feb 18 '26	Sale	1.99	7,743	15,447	501,262	Feb 19 04:11 PM
Farokhzad Omid	CEO AND CHAIR	Feb 18 '26	Sale	1.99	24,385	48,646	3,349,064	Feb 19 04:06 PM
Horn David R.	PRESIDENT & CFO	Nov 19 '25	Sale	1.97	6,797	13,400	436,802	Nov 21 05:31 PM
Farokhzad Omid	CEO AND CHAIR	Nov 19 '25	Sale	1.97	33,838	66,708	1,238,230	Nov 21 05:29 PM

Seer, Inc. engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite consists of automation instruments and software, which provide a workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.

Ph.D.Dr. Omid C. Farokhzad M.D.

TreasurerMr. Charles Endweiss

Chief Operations & Product OfficerKenny Ross

Chief People OfficerMs. Marissa Dixon

Senior Vice President of Product DevelopmentMr. Martin Goldberg Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SEER

Seer Inc

Upgrade your Finviz experience